Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy tr
about
The Efficacy and Safety of the Combination of Total Glucosides of Peony and Leflunomide for the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-AnalysisStructural integrity versus radiographic progression in rheumatoid arthritisRheumatoid arthritis treatment: the earlier the better to prevent joint damageMy treatment approach to rheumatoid arthritisCD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisInterleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach.The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis.Measures in rheumatoid arthritis: are we measuring too many parameters.Biological therapies for rheumatoid arthritis: progress to date.What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.Current immunotherapy in rheumatoid arthritis.Is non-biological treatment of rheumatoid arthritis as good as biologics?The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences.Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.Efficacy assessed in follow-ups of clinical trials: methodological conundrumLarge-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.Correlation of structural abnormalities of the wrist and metacarpophalangeal joints evaluated by high-resolution peripheral quantitative computed tomography, 3 Tesla magnetic resonance imaging and conventional radiographs in rheumatoid arthritis.A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.
P2860
Q26752893-ADBFDA7E-A534-4ADA-A9DA-D9B97ECE3473Q26777897-270230BF-5CF5-4B10-B2D0-0897195D2003Q26777903-AC5D53EC-A315-41E5-A160-C8F91EF40CE3Q26829955-9E73ED50-0045-4720-99FB-A20455C40AB2Q28728734-B63FF8EA-E6A8-4F07-A351-B9F6CFB94F23Q34343286-FEFC583F-E214-436D-9AE5-FA97316951FCQ34374946-69E5049F-BA45-4D12-BE80-A7C3488860B7Q35084199-D5168ED9-F135-4525-B56B-07D1E0B4484BQ35961312-4B1FA944-6CB7-4E7A-94E6-BB28C96F558FQ37158360-0EA54EBD-B1E2-46B9-8A15-4341F251D538Q37587412-C346526F-2AB4-4768-AC74-EB7BCF7A6469Q38019622-EC8E679B-D93E-4352-823A-5055C208218DQ38096206-8F1D43B7-0ED1-4774-BEBF-1C4881EB23B7Q38097740-D018EB4D-D12F-4F2C-9550-B062CE201E69Q38133655-E7E77E78-CA58-4902-A42A-046362EC8641Q38385089-B1C115DB-4F0D-47F6-8F52-66CFE76E20F4Q38583927-519C03FD-7B90-478C-AEE4-0114F9A9A601Q40062771-F6A397EF-4D3C-4511-B635-979743FB5AD2Q41931049-9C381B09-9825-486F-91AE-7E97A22A5E17Q42420362-FED197ED-B9AD-4E69-84CD-AF515E19B421Q44864886-7FB053A4-DE76-490B-92BA-3DE8E8C88C2EQ46812771-02BE30D9-26BF-4C12-9017-0A494E634023Q51733704-58D94477-4C53-4452-B89F-7BEA4184D398
P2860
Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy tr
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Early combination disease-modi ...... thritis Combination Therapy tr
@ast
Early combination disease-modi ...... thritis Combination Therapy tr
@en
Early combination disease-modi ...... thritis Combination Therapy tr
@nl
type
label
Early combination disease-modi ...... thritis Combination Therapy tr
@ast
Early combination disease-modi ...... thritis Combination Therapy tr
@en
Early combination disease-modi ...... thritis Combination Therapy tr
@nl
prefLabel
Early combination disease-modi ...... thritis Combination Therapy tr
@ast
Early combination disease-modi ...... thritis Combination Therapy tr
@en
Early combination disease-modi ...... thritis Combination Therapy tr
@nl
P2093
P2860
P356
P1476
Early combination disease-modi ...... itis Combination Therapy trial
@en
P2093
Anna Karjalainen
FIN-RACo Trial Group
Hannu Kautiainen
Harri Blåfield
Kari Puolakka
Leena Laasonen
Marjatta Leirisalo-Repo
Markku Korpela
Pekka Hannonen
Salme Järvenpää
P2860
P2888
P356
10.1186/AR3060
P577
2010-06-24T00:00:00Z
P5875
P6179
1047498462